Chronic Spontaneous Urticaria Current and Emerging Biologic Agents

被引：0
|
作者：
Bernstein, Joshua S. [1 ]
Bernstein, Jonathan A. [1 ]
Lang, David M. [2 ]
机构：
[1] Univ Cincinnati, Div Rheumatol Allergy & Immunol, 234 Goodman St, Cincinnati, OH 45219 USA
[2] Cleveland Clin, Dept Allergy & Clin Immunol, 9500 Euclid Ave,A90, Cleveland, OH 44195 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2024年 / 44卷 / 04期
关键词：
Chronic spontaneous urticaria; Mast cell; Biologics; Omalizumab; Siglec-6; BTK inhibitor; MRGPRX2; C-kit; Dupilumab; CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA; MAST-CELLS; OMALIZUMAB; SKIN; CYTOKINES; LIGELIZUMAB; ACTIVATION; EXPRESSION; EOSINOPHIL; ANTIBODY;
D O I：
10.1016/j.iac.2024.07.001
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：595 / 613
页数：19
相关论文
共 50 条
  • [41] Current perspectives and future directions in the management of chronic spontaneous urticaria and their link to disease pathogenesis and biomarkers
    Gimenez-Arnau, Ana M.
    Podder, Indrashis
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 158 (04) : 302 - 315
  • [42] Unveiling the role of neutrophils in chronic spontaneous urticaria: Beyond mast cells
    Kulthanan, Kanokvalai
    Chularojanamontri, Leena
    Tuchinda, Papapit
    Buranaporn, Panyapat
    Karoopongse, Ekapun
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2023, 41 (03) : 179 - 185
  • [43] Ligelizumab for Chronic Spontaneous Urticaria
    Maurer, Marcus
    Gimenez-Arnau, Ana M.
    Sussman, Gordon
    Metz, Martin
    Baker, Diane R.
    Bauer, Andrea
    Bernstein, Jonathan A.
    Brehler, Randolf
    Chu, Chia-Yu
    Chung, Wen-Hung
    Danilycheva, Inna
    Grattan, Clive
    Hebert, Jacques
    Katelaris, Constance
    Makris, Michael
    Meshkova, Raisa
    Savic, Sinisa
    Sinclair, Rodney
    Sitz, Karl
    Staubach, Petra
    Wedi, Bettina
    Loeffler, Juergen
    Barve, Avantika
    Kobayashi, Kenneth
    Hua, Eva
    Severin, Thomas
    Janocha, Reinhold
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (14) : 1321 - 1332
  • [44] Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies
    Orzan, Olguta Anca
    Popa, Liliana Gabriela
    Mihai, Mara Madalina
    Cojocaru, Anca
    Giurcaneanu, Calin
    Dorobantu, Alexandra Maria
    MEDICINA-LITHUANIA, 2022, 58 (06):
  • [45] The Emerging Role of IL-17 in the Immune-Pathogenesis of Chronic Spontaneous Urticaria
    Toubi, Elias
    Vadasz, Zahava
    IMMUNOTARGETS AND THERAPY, 2020, 9 : 217 - 223
  • [46] Chronic spontaneous urticaria: new evidences on the role of autoimmunity
    Xiang, Yi-Kui
    Guloglu, Sercan
    Elieh-Ali-Komi, Daniel
    Kocatuerk, Emek
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 23 (05) : 438 - 445
  • [47] Biologics for the Use in Chronic Spontaneous Urticaria: When and Which
    Maurer, Marcus
    Khan, David A.
    Komi, Daniel Elieh Ali
    Kaplan, Allen P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03) : 1067 - 1078
  • [48] Recognition andmanagement of relevant comorbidities in chronic spontaneous urticaria
    Wagner, Nicola
    Berking, Carola
    DERMATOLOGIE, 2024, 75 (04): : 289 - 294
  • [49] Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria
    Termeer, Christian
    Staubach, Petra
    Kurzen, Hjalmar
    Stroemer, Klaus
    Ostendorf, Rolf
    Maurer, Marcus
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (05): : 419 - 429
  • [50] Omalizumab in chronic spontaneous urticaria: steroid sparing effect
    Gatta, Alessia
    Della Valle, Loredana
    Farinelli, Anila
    Cavallucci, Enrico
    Paganelli, Roberto
    Di Gioacchino, Mario
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 : 6 - 9
12345